GlycoMimetics Inc (GLYC)

0.402 +0.01 (+1.64%) USD  |  NASDAQ  |  Nov 13, 16:00
0.405 0.00 (0.00%) After-Hours: 20:00
More

GlycoMimetics Free Cash Flow to Firm (Quarterly)

Free Cash Flow to Firm (Quarterly) Chart

View Free Cash Flow to Firm (Quarterly) for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Free Cash Flow to Firm (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
September 30, 2014 --
June 30, 2014 --
March 31, 2014 --
Date Value
December 31, 2013 --
September 30, 2013 --
June 30, 2013 --

Free Cash Flow to the Firm Definition

Free cash flow to firm measures the total cash flow available after all expenses and investments. This metric can give a good idea of the health of a company's operations.

Read full definition.

Free Cash Flow to Firm (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow to Firm (Quarterly) Benchmarks

Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp --
Revance Therapeutics Inc Upgrade
FibroGen Inc Upgrade
Cidara Therapeutics Inc Upgrade

Free Cash Flow to Firm (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Cash from Investing (Quarterly) Upgrade
Cash from Financing (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow Per Share (Quarterly) Upgrade
Free Cash Flow Yield Upgrade